Evaxion Biotech A/S (EVAX) Stock Chart & Stock Price History $0.88 -0.08 (-7.98%) (As of 03:22 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Evaxion Biotech A/S Stock Price Performance 5 Day Performance-16.11%1 Month Performance-43.75%3 Month Performance-69.35%6 Month Performance-64.97%Year-To-Date Performance-86.05%1 Year Performance-85.49% Receive EVAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. EVAX Stock Chart for Wednesday, December, 18, 2024 EVAX Chart by TradingView Evaxion Biotech A/S Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$1.05$0.96-8.92%$1.20$0.91153,280 shs$5.61 million12/16/2024$1.14$1.05-7.89%$1.15$0.94155,027 shs$6.16 million12/13/2024$1.19$1.14-4.20%$1.22$1.0982,068 shs$6.69 million12/12/2024$1.30$1.19-8.46%$1.30$1.08522,786 shs$6.98 million12/11/2024$1.29$1.30+0.78%$1.30$1.2056,990 shs$7.63 million12/10/2024$1.36$1.29-5.15%$1.39$1.2150,830 shs$7.57 million Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$1.34$1.36+1.49%$1.41$1.1964,460 shs$7.98 million12/06/2024$1.38$1.34-2.90%$1.49$1.3114,835 shs$7.86 million12/05/2024$1.43$1.38-3.50%$1.59$1.3839,897 shs$8.10 million12/04/2024$1.45$1.43-1.38%$1.52$1.4026,664 shs$8.39 million12/03/2024$1.54$1.45-5.84%$1.59$1.4516,229 shs$8.51 million12/02/2024$1.66$1.54-7.23%$1.69$1.5036,669 shs$9.03 million11/29/2024$1.57$1.66+5.73%$1.71$1.566,610 shs$9.74 million11/28/2024$1.57$1.57$1.83$1.5555,605 shs$9.21 million11/27/2024$1.61$1.57-2.48%$1.83$1.5555,549 shs$9.22 million11/26/2024$1.57$1.61+2.55%$1.68$1.4836,494 shs$9.45 million11/25/2024$1.49$1.57+5.37%$1.76$1.4154,241 shs$9.22 million11/22/2024$1.37$1.49+8.76%$1.49$1.3613,402 shs$8.75 million11/21/2024$1.40$1.37-2.14%$1.48$1.3026,732 shs$8.04 million11/20/2024$1.54$1.40-9.09%$1.59$1.2846,351 shs$8.21 million11/19/2024$1.70$1.54-9.41%$1.80$1.3999,182 shs$9.03 million11/18/2024$1.44$1.70+18.06%$1.76$1.3670,689 shs$9.49 million Related Companies Senti Biosciences Stock Chart MiNK Therapeutics Stock Chart Calidi Biotherapeutics Stock Chart Athira Pharma Stock Chart IN8bio Stock Chart Cognition Therapeutics Stock Chart Finch Therapeutics Group Stock Chart Cyclo Therapeutics Stock Chart NKGen Biotech Stock Chart AIM ImmunoTech Stock Chart Receive EVAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EVAX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVAX Stock Alerts